Long-Term Exposure to Ultrafine Particles and Particulate Matter Constituents and the Risk of Amyotrophic Lateral Sclerosis

Note: Funding Information: This case–control study was funded by the ALS Foundation Netherlands; Prinses Beatrix Spierfonds; the European Community’s Health Seventh Framework Programme (grant agreements 259867 and 211250); Netherlands Organisation for Health Research and Development (ZonMW) under the frame of E-Rare-2, the European Research Area Network on Rare Diseases; EU Joint Programme Neurodegenerative Disease Research project [Sampling and biomarker OPtimization and Harmonization In ALS and other motor neuron diseases (SOPHIA) and Survival, Trigger and Risk, Epigenetic, eNvironmental and Genetic Targets for motor neuron Health (STRENGTH) projects]; and the ZonMW Vici scheme to L. v.d.B. Z.Y. was supported by a scholarship from the Chinese Scholarship Council. M.-A.K. was supported by the National Institutes of Health/National Institute of Environmental Health Science (R21 ES028472 and R01 ES028805).